1996—2001年住院复治肺结核患者结核分枝杆菌耐药性的调查

摘要/Abstract

摘要： 目的　探讨住院复治肺结核患者的耐药情况。方法对1996—2001年培养阳性的1385例住院肺结核患者中440例复治肺结核患者的耐药情况按年龄分组进行回顾性分析。结果总耐药率以青年组最高。耐2药及以上者比例较耐1药比例高,青年组耐R率明显高于老年组;耐2药中,以耐HR占首位。总的耐多药率为49.5%,青年组高达73.9%。结论复治肺结核患者的高耐药率应引起足够重视,需采取更多措施降低耐药率。

关键词: 结核,肺, 分枝杆菌,结核, 抗药性

Abstract: Objective To investigate the situation of drug resistance of hospitalized previously treated pulmonary tuberculosis patients.Method To analyze and compare the drug resistance of 440 cases of retreated pulmonary tuberculosis from 1385 baterilogical positive pulmonary tuberculosis cases during 1996-2001.Results The total rate of drug resistance in youth group was the highest.The proportion of 2 and above drugs resistance was higher than that of 1 drugresistance.The rate of R resistance in youth group was obviously higher than that in old age group.The rate of HR resistance was the highest in 2 drug resistance group.The total rate of multi-drug resistance was 49.5%,but that in youth group was as high as 73.9%.Conclusion We should pay more attention to the grave situation of drug resistance of the patients with retreated pulmonasy tuberculosis.It is important to take the more measures to reduce the rate of drug resistance.

Key words: Tuberculosis,pulmonary, Mycobacterium tuberculosis, Drug resistance

任来兴,桂徐蔚,夏祥新,唐神结,吴小珍,张莹蓉,. 1996—2001年住院复治肺结核患者结核分枝杆菌耐药性的调查[J]. 中国防痨杂志, 2005, 27(5): 310-312.

Ren Laixing,Gui Xuwei,Xia Xiangxin,et al.. The investigation on drug resistance of hospitalized previously retreated tuberculosis patients during 1996-2001 in our hospital[J]. Chinese Journal of Antituberculosis, 2005, 27(5): 310-312.

[1]	包训迪, 江跃, 梁锁, 程红燕, 夏广秀, 王超, 叶倩, 王舒, 王庆. 安徽省非结核分枝杆菌临床分离率及人群分布和耐药性分析[J]. 中国防痨杂志, 2020, 42(7): 718-724.
[2]	高天慧,舒薇,高静韬,陆宇,李琦. 254例耐药肺结核患者克拉霉素耐药情况及影响因素分析[J]. 中国防痨杂志, 2020, 42(3): 259-265.
[3]	陈燕梅,黄新春,孙琦,张晨晨,温文沛,陈亮. 2016年广东省涂阴培阳肺结核患者耐药情况分析[J]. 中国防痨杂志, 2020, 42(3): 272-275.
[4]	李冰莹, 郑旭彬, 胡屹, 徐飚. 全基因组数据分析工具TB Profiler v2.8.0、Mykrobe v0.7.0和PhyResSE v1.0在耐药结核病检测中的价值[J]. 中国防痨杂志, 2020, 42(11): 1196-1202.
[5]	宋克玉, 张琴, 王雯菁, 时瑞, 吴旭平. 2017—2019年南京市1719株分枝杆菌耐药情况分析[J]. 中国防痨杂志, 2020, 42(11): 1214-1220.
[6]	刘原园, 初平, 韩书婧, 杨慧, 鲁洁. 结核分枝杆菌对德拉马尼的耐药机制研究进展[J]. 中国防痨杂志, 2020, 42(11): 1237-1242.
[7]	申丽君,王艺曈,李雪,刘昭,张帆,赵琨,刘跃华. 基于疗程费用测算耐药结核病患者药物负担[J]. 中国防痨杂志, 2019, 41(9): 962-967.
[8]	刘东鑫,郑惠文,贺文从,宋怡蒙,何萍,赵冰,欧喜超,刘春法,赵雁林. 广州市非结核分枝杆菌临床分离株菌种鉴定及药物敏感性试验结果分析[J]. 中国防痨杂志, 2019, 41(5): 534-540.
[9]	刘元,周俊,崔晓利,雷佳媛,赵国连,党丽云. GeneXpert MTB/RIF检测结核分枝杆菌对利福平耐药假阳性与标本低水平荷菌量的关系[J]. 中国防痨杂志, 2019, 41(2): 176-180.
[10]	张俊仙,吴雪琼. 结核分枝杆菌耐药性检测方法的研究进展[J]. 中国防痨杂志, 2019, 41(2): 227-232.
[11]	张叶,李媛媛,徐建,陈曦,王彬,付雷,陆宇. 吡法齐明抗耐药结核分枝杆菌作用机制的初步研究[J]. 中国防痨杂志, 2019, 41(11): 1160-1166.
[12]	石莲,任轶杰,奚莹,石蕾,郭晨,关建. 三种实验室技术在涂阳患者中诊断肺结核及其耐药性的效能分析[J]. 中国防痨杂志, 2019, 41(11): 1173-1178.
[13]	罗明,张汇征,严晓峰,陈耀凯,黄正谷,周刊,李同心,李俊刚,王静,廖传玉. 40株耐多药结核分枝杆菌临床分离株对利奈唑胺及特地唑胺药物敏感性的研究[J]. 中国防痨杂志, 2019, 41(10): 1124-1126.
[14]	吴培丰,温颖,陈嘉,高颖龙,白静,王向阳,吴健. 广东口岸结核分枝杆菌复合群分子流行病学特征分析[J]. 中国防痨杂志, 2018, 40(9): 973-978.
[15]	宋艳华,王桂荣,霍凤敏,刘荣梅,高孟秋,李琦. 耐多药和广泛耐药MTB的inhA基因突变与对丙硫异烟胺耐药的相关性分析[J]. 中国防痨杂志, 2018, 40(8): 821-824.

1996—2001年住院复治肺结核患者结核分枝杆菌耐药性的调查

The investigation on drug resistance of hospitalized previously retreated tuberculosis patients during 1996-2001 in our hospital

PDF (PC)

可视化

摘要/Abstract

引用本文

使用本文

参考文献

相关文章 15

编辑推荐

Metrics

本文评价

友情链接